Mark Heinen serves as Executive at Better Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Mark Heinen has executed 13 insider transactions totaling $141.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 7, 2024 involved receiving (via award) 139,463 shares valued at $0.
Mark Heinen currently holds 147,963 shares of Better Therapeutics, Inc. (BTTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Heinen has been a net buyer of BTTX stock. They have purchased $141.9K and sold $0 worth of shares.
Mark Heinen's most recent insider trade was on Jun 7, 2024, when they sold 139,463 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.80 |
| Discretionary |
| Apr 5, 2023 | BTTX | $0 | Award | 54,000 | $N/A | Discretionary |
| Nov 30, 2022 | BTTX | $19.5K | Award | 15,723 | $1.24 | Discretionary |
| Sep 13, 2022 | BTTX | $50.7K | Purchase | 26,132 | $1.94 | Discretionary |
| Sep 12, 2022 | BTTX | $46.3K | Purchase | 23,868 | $1.94 | Discretionary |
| Jun 24, 2022 | BTTX | $4.0K | Purchase | 2,280.61 | $1.75 | Discretionary |
| Jun 10, 2022 | BTTX | $7.8K | Purchase | 5,000 | $1.56 | Discretionary |
| Mar 31, 2022 | BTTX | $9.9K | Purchase | 5,000 | $1.98 | Discretionary |
| Dec 15, 2021 | BTTX | $11.0K | Purchase | 2,333 | $4.70 | Discretionary |
| Dec 14, 2021 | BTTX | $2.7K | Purchase | 500 | $5.44 | Discretionary |
| Dec 13, 2021 | BTTX | $2.7K | Purchase | 500 | $5.45 | Discretionary |
| Oct 28, 2021 | BTTX | $0 | Award | 6,667 | $N/A | Discretionary |